Assertion: prescription drug's information | /r/RelatedTo | excitability
Facets:
Source sentences:
text: Level 4 - Move 'point of use' warning information With the exception of information related to drowsiness or excitability that may occur with use of the product, the following 'point of use' warnings (i.e., information which is important to the consumer when taking the product, but which is not necessarily needed at the point of selection) can be moved from the outer label or package and included in a package insert and, if desired, an eCDFT (with conditions, see below): 'When using this product' subsection